Dongwha Pharm.Co.Ltd
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, d… Read more
Dongwha Pharm.Co.Ltd (000020) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.003x
Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) has a cash flow conversion efficiency ratio of -0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.37 Billion) by net assets (₩402.11 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Dongwha Pharm.Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Dongwha Pharm.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Dongwha Pharm.Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dongwha Pharm.Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pharmaniaga Bhd
KLSE:7081
|
0.215x |
|
AME Elite Consortium Bhd
KLSE:5293
|
0.099x |
|
Victek Co. Ltd
KQ:065450
|
-0.047x |
|
DRTECH Corporation
KQ:214680
|
-0.050x |
|
Administradora Americana de Inversiones S.A.
SN:AAISA
|
N/A |
|
Monument Mining Limited
PINK:MMTMF
|
0.113x |
|
Jw Life Science Corp
KO:234080
|
0.053x |
|
Pyridam Farma Tbk
JK:PYFA
|
-0.213x |
Annual Cash Flow Conversion Efficiency for Dongwha Pharm.Co.Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Dongwha Pharm.Co.Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩401.68 Billion | ₩-4.00 Billion | -0.010x | -113.91% |
| 2023-12-31 | ₩407.06 Billion | ₩29.17 Billion | 0.072x | -7.15% |
| 2022-12-31 | ₩378.67 Billion | ₩29.22 Billion | 0.077x | -22.87% |
| 2021-12-31 | ₩360.13 Billion | ₩36.03 Billion | 0.100x | -34.35% |
| 2020-12-31 | ₩342.68 Billion | ₩52.23 Billion | 0.152x | +245.17% |
| 2019-12-31 | ₩300.87 Billion | ₩13.28 Billion | 0.044x | +401.18% |
| 2018-12-31 | ₩297.40 Billion | ₩-4.36 Billion | -0.015x | +73.65% |
| 2017-12-31 | ₩296.94 Billion | ₩-16.52 Billion | -0.056x | -155.22% |
| 2016-12-31 | ₩252.93 Billion | ₩25.48 Billion | 0.101x | +16.90% |
| 2015-12-31 | ₩230.12 Billion | ₩19.83 Billion | 0.086x | +46.50% |
| 2014-12-31 | ₩229.73 Billion | ₩13.51 Billion | 0.059x | +62.92% |
| 2013-12-31 | ₩227.23 Billion | ₩8.21 Billion | 0.036x | -67.51% |
| 2012-12-31 | ₩226.99 Billion | ₩25.23 Billion | 0.111x | -44.82% |
| 2011-12-31 | ₩229.62 Billion | ₩46.24 Billion | 0.201x | -- |